LV13544B - Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium - Google Patents
Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium Download PDFInfo
- Publication number
- LV13544B LV13544B LVP-05-95A LV050095A LV13544B LV 13544 B LV13544 B LV 13544B LV 050095 A LV050095 A LV 050095A LV 13544 B LV13544 B LV 13544B
- Authority
- LV
- Latvia
- Prior art keywords
- meldonium
- azt
- pharmaceutical composition
- oct
- content
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-05-95A LV13544B (en) | 2005-08-15 | 2005-08-15 | Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium |
EEP200800014A EE05529B1 (et) | 2005-08-15 | 2006-08-08 | Ravimikoostis, mis on valmistatud prdtranskriptaasi inhibiitori ja meldooniumi baasil |
US11/990,285 US7700576B2 (en) | 2005-08-15 | 2006-08-08 | Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium |
EP06783790A EP1933823B1 (en) | 2005-08-15 | 2006-08-08 | Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium |
JP2008526897A JP5027809B2 (ja) | 2005-08-15 | 2006-08-08 | 逆転写酵素阻害剤およびメルドニウムに基づく医薬組成物 |
AT06783790T ATE493123T1 (de) | 2005-08-15 | 2006-08-08 | Pharmazeutische zusammensetzung auf basis eines reversen transkriptase-hemmers und meldonium |
CN2006800298828A CN101252925B (zh) | 2005-08-15 | 2006-08-08 | 以逆转录酶抑制剂和美度铵为基础的药物组合物 |
UAA200803268A UA90162C2 (ru) | 2005-08-15 | 2006-08-08 | Фармацевтическая композиция на основе ингибитора обратной транскриптазы и мелдония |
ES06783790T ES2361185T3 (es) | 2005-08-15 | 2006-08-08 | Composición farmacéutica basada en inhibidor de la transcriptasa inversa y meldonio. |
PCT/LV2006/000005 WO2007021164A1 (en) | 2005-08-15 | 2006-08-08 | Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium |
DE602006019293T DE602006019293D1 (de) | 2005-08-15 | 2006-08-08 | Pharmazeutische zusammensetzung auf basis eines reversen transkriptase-hemmers und meldonium |
ARP060103527A AR066995A1 (es) | 2005-08-15 | 2006-08-11 | Composicion farmeceutica sobre la base de inhibidor de transcriptasa inversa y meldonio |
UY29751A UY29751A1 (es) | 2005-08-15 | 2006-08-14 | Composicion farmaceutica basada en el inhibidor de la transcriptasa inversa y meldonio |
PE2006000983A PE20070233A1 (es) | 2005-08-15 | 2006-08-14 | Composiciones farmaceuticas en base a inhibidores de transcriptasa inversa y meldonium |
HN2006029085A HN2006029085A (es) | 2005-08-15 | 2006-08-15 | Compuestos farmaceuticos a base de un inhibidor de transcriptasa reversa y meldonio |
SV2006002655A SV2007002655A (es) | 2005-08-15 | 2006-08-15 | Composición farmacéutica sobre la base de inhibidor de transcriptasa inversa y meldonio |
LT2008003A LT5524B (lt) | 2005-08-15 | 2008-01-18 | Farmacinė kompozicija, kurios pagrindą sudaro atvirkštinės transkriptazės inhibitorius ir meldoniumas |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-05-95A LV13544B (en) | 2005-08-15 | 2005-08-15 | Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium |
Publications (1)
Publication Number | Publication Date |
---|---|
LV13544B true LV13544B (en) | 2007-05-20 |
Family
ID=37442067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-05-95A LV13544B (en) | 2005-08-15 | 2005-08-15 | Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium |
Country Status (17)
Country | Link |
---|---|
US (1) | US7700576B2 (es) |
EP (1) | EP1933823B1 (es) |
JP (1) | JP5027809B2 (es) |
CN (1) | CN101252925B (es) |
AR (1) | AR066995A1 (es) |
AT (1) | ATE493123T1 (es) |
DE (1) | DE602006019293D1 (es) |
EE (1) | EE05529B1 (es) |
ES (1) | ES2361185T3 (es) |
HN (1) | HN2006029085A (es) |
LT (1) | LT5524B (es) |
LV (1) | LV13544B (es) |
PE (1) | PE20070233A1 (es) |
SV (1) | SV2007002655A (es) |
UA (1) | UA90162C2 (es) |
UY (1) | UY29751A1 (es) |
WO (1) | WO2007021164A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA021588B1 (ru) * | 2009-06-25 | 2015-07-30 | Тетра Сиа | Бетаиновые соли ацетилсалициловой кислоты |
LV14848B (lv) * | 2012-10-25 | 2015-06-20 | Latvijas Organiskās Sintēzes Institūts | Farmaceitiska kompozīcija trimetilamīna-N-oksīda līmeņa pazemināšanai |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU997646A1 (ru) | 1978-11-27 | 1983-02-23 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср | Кормова добавка |
US4724232A (en) | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
US5130421A (en) | 1988-03-24 | 1992-07-14 | Bristol-Myers Company | Production of 2',3'-dideoxy-2',3'-didehydronucleosides |
GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
IT1255039B (it) | 1992-03-11 | 1995-10-13 | Sigma Tau Ind Farmaceuti | Impiego di l-carnitina nel trattamento di pazienti hiv-sieropositivi presentanti deficit di carnitina. |
-
2005
- 2005-08-15 LV LVP-05-95A patent/LV13544B/lv unknown
-
2006
- 2006-08-08 DE DE602006019293T patent/DE602006019293D1/de active Active
- 2006-08-08 US US11/990,285 patent/US7700576B2/en not_active Expired - Fee Related
- 2006-08-08 EP EP06783790A patent/EP1933823B1/en active Active
- 2006-08-08 JP JP2008526897A patent/JP5027809B2/ja not_active Expired - Fee Related
- 2006-08-08 AT AT06783790T patent/ATE493123T1/de not_active IP Right Cessation
- 2006-08-08 CN CN2006800298828A patent/CN101252925B/zh not_active Expired - Fee Related
- 2006-08-08 UA UAA200803268A patent/UA90162C2/ru unknown
- 2006-08-08 EE EEP200800014A patent/EE05529B1/xx not_active IP Right Cessation
- 2006-08-08 ES ES06783790T patent/ES2361185T3/es active Active
- 2006-08-08 WO PCT/LV2006/000005 patent/WO2007021164A1/en active Application Filing
- 2006-08-11 AR ARP060103527A patent/AR066995A1/es unknown
- 2006-08-14 UY UY29751A patent/UY29751A1/es not_active Application Discontinuation
- 2006-08-14 PE PE2006000983A patent/PE20070233A1/es not_active Application Discontinuation
- 2006-08-15 HN HN2006029085A patent/HN2006029085A/es unknown
- 2006-08-15 SV SV2006002655A patent/SV2007002655A/es not_active Application Discontinuation
-
2008
- 2008-01-18 LT LT2008003A patent/LT5524B/lt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101252925A (zh) | 2008-08-27 |
LT2008003A (en) | 2008-07-25 |
JP2009504731A (ja) | 2009-02-05 |
UY29751A1 (es) | 2007-03-30 |
UA90162C2 (ru) | 2010-04-12 |
DE602006019293D1 (de) | 2011-02-10 |
WO2007021164A1 (en) | 2007-02-22 |
US7700576B2 (en) | 2010-04-20 |
AR066995A1 (es) | 2009-09-30 |
ES2361185T3 (es) | 2011-06-14 |
HN2006029085A (es) | 2007-11-16 |
EE05529B1 (et) | 2012-04-16 |
EP1933823B1 (en) | 2010-12-29 |
JP5027809B2 (ja) | 2012-09-19 |
EP1933823A1 (en) | 2008-06-25 |
ATE493123T1 (de) | 2011-01-15 |
EE200800014A (et) | 2008-06-16 |
SV2007002655A (es) | 2007-04-12 |
US20090137522A1 (en) | 2009-05-28 |
CN101252925B (zh) | 2012-04-25 |
PE20070233A1 (es) | 2007-06-08 |
LT5524B (lt) | 2008-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2433476T3 (es) | Combinaciones que contienen inhibidores de la dipeptidilpeptidasa-IV y agentes 5 antidiabéticos | |
Desager | Clinical pharmacokinetics of ticlopidine | |
JP6153281B1 (ja) | 細胞内atp増強剤 | |
PT1171137E (pt) | Utilização de triacetiluridina para o tratamento de perturbações mitocondriais | |
BE1004168A3 (fr) | Utilisation de n-acylcysteines dans le traitement de maladies associees aux infections par hiv. | |
CN107920577A (zh) | 协同饮料组合物 | |
Wood et al. | Drug-induced psychosis and depression in the elderly | |
Das et al. | RETRACTED Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling | |
JP2024016228A (ja) | アセトアミノフェン(apap)によって引き起こされる毒性を予防、低減または根絶するための方法および組成物 | |
LV13544B (en) | Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium | |
US6040346A (en) | Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs | |
JP2022544718A (ja) | 敗血症性心筋症を治療するための組成物および方法 | |
Lemberg et al. | Tolerabilities of antiretrovirals in paediatric HIV infection | |
US9259411B2 (en) | Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors | |
Breglia et al. | Effect of selected amino acids on ethanol toxicity in rats | |
US11826334B2 (en) | Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus | |
CA2878190A1 (en) | Pharmaceutical composition for reducing the trimethylamine n-oxide level | |
Wheeler et al. | Zidovudine‐induced diaphragmatic contractile dysfunction: Impact of an antioxidant diet | |
Sikora et al. | From Gym to Medicine: Creatine Uses Beyond Athletic Performance | |
CN116808224A (zh) | 用于治疗血管疾病的化合物组合 | |
Fava et al. | S-adenosyl-L-methionine as an Antidepressant Results of a MEDLINE Search by, Ivan Goldberg, MD | |
Growdon et al. | Choline administration to patients with Huntington’s disease or tardive dyskinesia | |
CN1223582A (zh) | 用噻唑烷酮治疗和预防神经变性疾病的方法 | |
Germanyuk et al. | General pharmacology and pharmacology of the drugs affecting mediatory processes, vegetative and central nervous systems | |
Sanders et al. | Induction of thymic lymphoma in mice administered the dideoxynucleoside ddC |